ID

33055

Descripción

This form contains a form to document the date of visit, liver events, investigational product (liver) and the pharmacokinetics. To be assessed at liver event visit. Study ID: 103629 Clinical Study ID: TRX103629 Study Title: An open-label, randomized, 3-period crossover study to evaluate sumatriptan and naproxen pharmacokinetics for a combination tablet product containing sumatriptan/naproxen sodium followed by IMITREX™ (sumatriptan succinate) Injection 4mg administered using the IMITREX STATdose System and a sumatriptan/naproxen sodium tablet followed by IMITREX (sumatriptan succinate) Injection 6mg administered using the STATdose system compared with an IMITREX tablet 100mg followed by an IMITREX tablet 100mg Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00875784 Clinicaltrials.gov link: https://clinicaltrials.gov/ct2/show/NCT00875784 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: phase 1 Study Recruitment Status: Completed Generic Name: sumatriptan Trade Name: Imitrex ,Imiject ,Imigran; Imitrex,Imiject,Imigran Study Indication: Migraine Disorders

Link

https://clinicaltrials.gov/ct2/show/NCT00875784

Palabras clave

Versiones (1)
  1. 25/11/18 25/11/18 -
Titular de derechos de autor

GlaxoSmithKline

Subido en

25 de noviembre de 2018

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY-NC 3.0
Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Volver a los comentarios del modelo
Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Sumatriptan pharmacokinetics for TREXIMA/IMITREX ID 103629

Inglés

Liver Event: Date of Visit, Liver Events, Investigational Product (Liver) and Pharmacokinetics

1 formularios  
Administrative Data
Descripción

Administrative Data

Alias
UMLS CUI-1
C1320722
Subject Identifier
Descripción

Subject Identifier

Tipo de datos

integer

Alias
UMLS CUI [1]
C2348585
Date of visit/assessment
Descripción

Date of Visit/Assessment

Tipo de datos

date

Alias
UMLS CUI [1]
C1320303
Liver Events Assessment
Descripción

Liver Events Assessment

Alias
UMLS CUI-1
C0023884
UMLS CUI-2
C0877248
UMLS CUI-3
C0220825
Have liver chemistry results reached or exceeded protocol-defined investigational product stopping criteria?
Descripción

(If no liver event, tick 'No' and enter date of study conclusion/withdrawal above) If Yes, stop investigational 1> roduct, complete date stopped on Investigational Product form, contact GSK within 24 hours of occurrence, complete Liver Events Form and obtain the following tests: * PK blood sample within 24 hours of last dose (or 3x the investigational product half life or tl/2: protocol specified longer value to be inserted). * Hepatitis A: Hepatitis A IgM antibody. * Hepatitis B: Hepatitis B surface antigen ,md Hepatitis B Core Antibody (IgM). * Hepatitis C: Hepatitis C RNA. * Hepatitis E lgM ,mtibody (if subjed resides or has trnvelled in the past 3 months outside the USA or Canadll). * Cytomegalovirus lgM antibody (CMV). * EBY (Epstein Barr virn1 capsid antigen IgM antibody) or if unavailable, obtain heterophile antibody or monospot testing.) * Bilirubin frnctionation, if bilirubin >= l.5xULN * CPK (serum creatine phosphokinase), * LDH (lactate dehydrogenase). The following are only needed when ALT >=3xULN and bilirubin >=t.SxULN (>35% direct) * Anti-nuclear antibody * Anti-smooth muscle antibody * Type I anti-liver kidney microsomal antibodies (if available) * Liver Imaging (ultrnsound, magnetic resonance, or computerised tomography) lf Yes, complete the Liver Event fonns displayed upon submission of this form Record the details of any Adverse Events or exacerbations of Adverse Events on the Non-Serious Adverse Event Form or the Serious Adverse Event form, Exacerbations of Adverse Events include increases in frequency and severity. It is particularly important to record any significant hypotension immediately prior to or concomitant with ALT elevation. It is particularly important to record any gallbladder or biliary disease, or pancreatitis, that occurred during the study.

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0023901
UMLS CUI [1,2]
C0587081
UMLS CUI [1,3]
C2133636
Which liver chemistry result reached or exceeded protocol-defined investigational product stopping criteria? ALT (alanine aminotransferase)
Descripción

Did ALT reach or exceed the investigational product stopping criteria?

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0201836
UMLS CUI [1,2]
C1521733
UMLS CUI [1,3]
C2133636
Which liver chemistry result reached or exceeded protocol-defined investigational product stopping criteria? AST (aspartate aminotransferase)
Descripción

Did AST reach or exceed the investigational product stopping criteria?

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0201899
UMLS CUI [1,2]
C1521733
UMLS CUI [1,3]
C2133636
Which liver chemistry result reached or exceeded protocol-defined investigational product stopping criteria? Total bilirubin
Descripción

Did the total bilirubin reach or exceed the investigational product stopping criteria?

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0201913
UMLS CUI [1,2]
C1521733
UMLS CUI [1,3]
C2133636
Which liver chemistry result reached or exceeded protocol-defined investigational product stopping criteria? Alkaline phosphatase
Descripción

Did the alkaline phosphatase reach or exceed the investigational product stopping criteria?

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0201850
UMLS CUI [1,2]
C1521733
UMLS CUI [1,3]
C2133636
Which liver chemistry result reached or exceeded protocol-defined investigational product stopping criteria? 5' nucleotidase
Descripción

Did the 5' nucleotidase reach or exceed the investigational product stopping criteria?

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0740292
UMLS CUI [1,2]
C1521733
UMLS CUI [1,3]
C2133636
Which liver chemistry result reached or exceeded protocol-defined investigational product stopping criteria? Gammaglutamyltranspeptidase
Descripción

Did the gammaglutamyltranspeptidase reach or exceed the investigational product stopping criteria?

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0541979
UMLS CUI [1,2]
C1521733
UMLS CUI [1,3]
C2133636
Which liver chemistry result reached or exceeded protocol-defined investigational product stopping criteria? Other
Descripción

Did another liver chemistry result reach or exceed the investigational product stopping criteria?

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0232741
UMLS CUI [1,2]
C0008000
UMLS CUI [1,3]
C0587081
UMLS CUI [1,4]
C0205394
UMLS CUI [1,5]
C1521733
UMLS CUI [1,6]
C2133636
Is the subject age 55 or older?
Descripción

Subject age

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0001779
If female, is the subject pregnant?
Descripción

If yes, ensure Pregnancy Notification Fonn has been completed.

Tipo de datos

text

Alias
UMLS CUI [1]
C0032961
Were any diagnostic imaging tests of the liver or hepatobiliary system performed (such as liver ultrasound, computerised tomography or CAT scan, magnetic resonance imaging or MRI, or endoscopic retrograde cholangiopancreatography, or other)?
Descripción

Performance of any diagnostic imaging tests of the liver or hepatobiliary syste (such as ultrasound, CAT scan, MRI, endoscopic retrograde cholangiopancreatography)

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0011923
UMLS CUI [1,2]
C1711359
UMLS CUI [1,3]
C0023884
UMLS CUI [2,1]
C1456803
UMLS CUI [2,2]
C0023884
UMLS CUI [3]
C0412620
UMLS CUI [4]
C0024485
UMLS CUI [5]
C0008310
If 'Yes' was ticked, were the results normal?
Descripción

If No, record the details on the Non-Serious Adverse Events form or Serious Adverse Events form.

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0011923
UMLS CUI [1,2]
C1711359
UMLS CUI [1,3]
C0023884
UMLS CUI [1,4]
C1274040
Were any liver biopsies performed?
Descripción

If yes, complete Liver Biopsy form

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0193388
Does the subject use herbals, complementary or alternative medicines, food supplements (vitamins) or illicit drugs?
Descripción

If yes, record on the appropriate Concomitant Medication form

Tipo de datos

boolean

Alias
UMLS CUI [1]
C2240391
UMLS CUI [2]
C1148474
UMLS CUI [3]
C0002346
UMLS CUI [4]
C0242295
UMLS CUI [5]
C0281875
Did the subject fast or undergo significant dietary change in the past week?
Descripción

Recent fasting or significant dietary change

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C3671772
UMLS CUI [1,2]
C0332185
UMLS CUI [2,1]
C0015663
UMLS CUI [2,2]
C0332185
Investigational Product (Liver)
Descripción

Investigational Product (Liver)

Alias
UMLS CUI-1
C0304229
UMLS CUI-2
C0023884
Start Date Investigational Product
Descripción

If the liver event occurred during treatment period record start and stop date of investigational product for that treatment period.

Tipo de datos

date

Alias
UMLS CUI [1,1]
C0877248
UMLS CUI [1,2]
C0023884
UMLS CUI [1,3]
C2745955
UMLS CUI [1,4]
C0087111
UMLS CUI [1,5]
C1948053
UMLS CUI [1,6]
C0304229
UMLS CUI [1,7]
C0808070
Not applicable
Descripción

Start Date Investigational Product Not applicable (Liver event occured during treatment period)

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0808070
UMLS CUI [1,2]
C0304229
UMLS CUI [1,3]
C1272460
End Date Investigational Product
Descripción

If the liver event occurred during treatment period record start and stop date of investigational product for that treatment period.

Tipo de datos

date

Alias
UMLS CUI [1,1]
C0877248
UMLS CUI [1,2]
C0023884
UMLS CUI [1,3]
C2745955
UMLS CUI [1,4]
C0087111
UMLS CUI [1,5]
C1948053
UMLS CUI [1,6]
C0304229
UMLS CUI [1,7]
C0806020
Not applicable
Descripción

End Date Investigational Product Not applicable (Liver event occured during treatment period)

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0304229
UMLS CUI [1,2]
C0806020
UMLS CUI [1,3]
C1272460
Start Date Investigational Product
Descripción

If the liver event occurred after treatment period record start and stop date of investigational product for the most recent period prior to the liver event.

Tipo de datos

date

Alias
UMLS CUI [1,1]
C0877248
UMLS CUI [1,2]
C0023884
UMLS CUI [1,3]
C2745955
UMLS CUI [1,4]
C0087111
UMLS CUI [1,5]
C0032756
UMLS CUI [1,6]
C1948053
UMLS CUI [1,7]
C0304229
UMLS CUI [1,8]
C0808070
Not applicable
Descripción

Start Date Investigational Product Not applicable (Liver event occured after treatment period)

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0808070
UMLS CUI [1,2]
C0304229
UMLS CUI [1,3]
C1272460
End Date Investigational Product
Descripción

If the liver event occurred after treatment period record start and stop date of investigational product for the most recent period prior to the liver event.

Tipo de datos

date

Alias
UMLS CUI [1,1]
C0877248
UMLS CUI [1,2]
C0023884
UMLS CUI [1,3]
C2745955
UMLS CUI [1,4]
C0087111
UMLS CUI [1,5]
C0032756
UMLS CUI [1,6]
C1948053
UMLS CUI [1,7]
C0304229
UMLS CUI [1,8]
C0806020
Not applicable
Descripción

End Date Investigational Product Not applicable (Liver event occured after treatment period)

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0304229
UMLS CUI [1,2]
C0806020
UMLS CUI [1,3]
C1272460
Pharmacokinetics
Descripción

Pharmacokinetics

Alias
UMLS CUI-1
C0031327
Was a pharmacokinetic blood sample obtained?
Descripción

An unscheduled PK blood sample must be obtained within 24 hours of last dose (or 3x the investigational product half-life or t1/2; protocol specified longer value to be inserted). If yes, document date and time sample taken in the next item as well as the date and time of last investigational product dose prior to PK sample and the Sample Identifier/Sample Number.

Tipo de datos

text

Alias
UMLS CUI [1,1]
C0031328
UMLS CUI [1,2]
C0005834
If a pharmacokinetic blood sample was obtained, date and time sample taken
Descripción

Date and time pharmacokinetic blood sample taken

Tipo de datos

datetime

Alias
UMLS CUI [1,1]
C1277698
UMLS CUI [1,2]
C0201734
UMLS CUI [1,3]
C1264639
If a pharmacokinetic blood sample was obtained, date and time of last investigational product dose prior to PK sample
Descripción

Date and time of last investigational product dose prior to PK sample

Tipo de datos

datetime

Alias
UMLS CUI [1,1]
C0304229
UMLS CUI [1,2]
C1762893
UMLS CUI [1,3]
C0946444
If a pharmacokinetic blood sample was obtained, Sample Identifier/Sample Number
Descripción

Sample Identifier/Sample Number if a pharmacokinetic blood sample was obtained

Tipo de datos

text

Alias
UMLS CUI [1]
C1299222
Volver a la parte superior de la página

Similar models

Liver Event: Date of Visit, Liver Events, Investigational Product (Liver) and Pharmacokinetics

1 formularios
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
Administrative Data
C1320722 (UMLS CUI-1)
Subject Identifier
Item
Subject Identifier
integer
C2348585 (UMLS CUI [1])
Date of Visit/Assessment
Item
Date of visit/assessment
date
C1320303 (UMLS CUI [1])
Item Group
Liver Events Assessment
C0023884 (UMLS CUI-1)
C0877248 (UMLS CUI-2)
C0220825 (UMLS CUI-3)
Liver chemistry reached or exceeded investigational product stopping criteria
Item
Have liver chemistry results reached or exceeded protocol-defined investigational product stopping criteria?
boolean
C0023901 (UMLS CUI [1,1])
C0587081 (UMLS CUI [1,2])
C2133636 (UMLS CUI [1,3])
Did ALT reach or exceed the investigational product stopping criteria?
Item
Which liver chemistry result reached or exceeded protocol-defined investigational product stopping criteria? ALT (alanine aminotransferase)
boolean
C0201836 (UMLS CUI [1,1])
C1521733 (UMLS CUI [1,2])
C2133636 (UMLS CUI [1,3])
Did AST reach or exceed the investigational product stopping criteria?
Item
Which liver chemistry result reached or exceeded protocol-defined investigational product stopping criteria? AST (aspartate aminotransferase)
boolean
C0201899 (UMLS CUI [1,1])
C1521733 (UMLS CUI [1,2])
C2133636 (UMLS CUI [1,3])
Did the total bilirubin reach or exceed the investigational product stopping criteria?
Item
Which liver chemistry result reached or exceeded protocol-defined investigational product stopping criteria? Total bilirubin
boolean
C0201913 (UMLS CUI [1,1])
C1521733 (UMLS CUI [1,2])
C2133636 (UMLS CUI [1,3])
Did the alkaline phosphatase reach or exceed the investigational product stopping criteria?
Item
Which liver chemistry result reached or exceeded protocol-defined investigational product stopping criteria? Alkaline phosphatase
boolean
C0201850 (UMLS CUI [1,1])
C1521733 (UMLS CUI [1,2])
C2133636 (UMLS CUI [1,3])
Did the 5' nucleotidase reach or exceed the investigational product stopping criteria?
Item
Which liver chemistry result reached or exceeded protocol-defined investigational product stopping criteria? 5' nucleotidase
boolean
C0740292 (UMLS CUI [1,1])
C1521733 (UMLS CUI [1,2])
C2133636 (UMLS CUI [1,3])
Did the gammaglutamyltranspeptidase reach or exceed the investigational product stopping criteria?
Item
Which liver chemistry result reached or exceeded protocol-defined investigational product stopping criteria? Gammaglutamyltranspeptidase
boolean
C0541979 (UMLS CUI [1,1])
C1521733 (UMLS CUI [1,2])
C2133636 (UMLS CUI [1,3])
Did another liver chemistry result reach or exceed the investigational product stopping criteria?
Item
Which liver chemistry result reached or exceeded protocol-defined investigational product stopping criteria? Other
boolean
C0232741 (UMLS CUI [1,1])
C0008000 (UMLS CUI [1,2])
C0587081 (UMLS CUI [1,3])
C0205394 (UMLS CUI [1,4])
C1521733 (UMLS CUI [1,5])
C2133636 (UMLS CUI [1,6])
Subject age
Item
Is the subject age 55 or older?
boolean
C0001779 (UMLS CUI [1])
Item
If female, is the subject pregnant?
text
C0032961 (UMLS CUI [1])
Pregnancy of female subject
Code List
If female, is the subject pregnant?
CL Item
Yes (Yes)
CL Item
No (No)
CL Item
Not applicable (Not applicable)
Performance of any diagnostic imaging tests of the liver or hepatobiliary syste (such as ultrasound, CAT scan, MRI, endoscopic retrograde cholangiopancreatography)
Item
Were any diagnostic imaging tests of the liver or hepatobiliary system performed (such as liver ultrasound, computerised tomography or CAT scan, magnetic resonance imaging or MRI, or endoscopic retrograde cholangiopancreatography, or other)?
boolean
C0011923 (UMLS CUI [1,1])
C1711359 (UMLS CUI [1,2])
C0023884 (UMLS CUI [1,3])
C1456803 (UMLS CUI [2,1])
C0023884 (UMLS CUI [2,2])
C0412620 (UMLS CUI [3])
C0024485 (UMLS CUI [4])
C0008310 (UMLS CUI [5])
Results of the diagnostic imaging tests of the liver or hepatobiliary system
Item
If 'Yes' was ticked, were the results normal?
boolean
C0011923 (UMLS CUI [1,1])
C1711359 (UMLS CUI [1,2])
C0023884 (UMLS CUI [1,3])
C1274040 (UMLS CUI [1,4])
Liver biopsies
Item
Were any liver biopsies performed?
boolean
C0193388 (UMLS CUI [1])
Use of herbals, complementary or alternative medicines, food supplements (vitamins) or illicit drugs?
Item
Does the subject use herbals, complementary or alternative medicines, food supplements (vitamins) or illicit drugs?
boolean
C2240391 (UMLS CUI [1])
C1148474 (UMLS CUI [2])
C0002346 (UMLS CUI [3])
C0242295 (UMLS CUI [4])
C0281875 (UMLS CUI [5])
Recent fasting or significant dietary change
Item
Did the subject fast or undergo significant dietary change in the past week?
boolean
C3671772 (UMLS CUI [1,1])
C0332185 (UMLS CUI [1,2])
C0015663 (UMLS CUI [2,1])
C0332185 (UMLS CUI [2,2])
Item Group
Investigational Product (Liver)
C0304229 (UMLS CUI-1)
C0023884 (UMLS CUI-2)
Start date of investigational product if liver event occured during treatment period
Item
Start Date Investigational Product
date
C0877248 (UMLS CUI [1,1])
C0023884 (UMLS CUI [1,2])
C2745955 (UMLS CUI [1,3])
C0087111 (UMLS CUI [1,4])
C1948053 (UMLS CUI [1,5])
C0304229 (UMLS CUI [1,6])
C0808070 (UMLS CUI [1,7])
Start Date Investigational Product Not applicable (Liver event occured during treatment period)
Item
Not applicable
boolean
C0808070 (UMLS CUI [1,1])
C0304229 (UMLS CUI [1,2])
C1272460 (UMLS CUI [1,3])
End date of investigational product if liver event occured during treatment period
Item
End Date Investigational Product
date
C0877248 (UMLS CUI [1,1])
C0023884 (UMLS CUI [1,2])
C2745955 (UMLS CUI [1,3])
C0087111 (UMLS CUI [1,4])
C1948053 (UMLS CUI [1,5])
C0304229 (UMLS CUI [1,6])
C0806020 (UMLS CUI [1,7])
End Date Investigational Product Not applicable (Liver event occured during treatment period)
Item
Not applicable
boolean
C0304229 (UMLS CUI [1,1])
C0806020 (UMLS CUI [1,2])
C1272460 (UMLS CUI [1,3])
Start date of investigational product if the liver event occured after treatment period
Item
Start Date Investigational Product
date
C0877248 (UMLS CUI [1,1])
C0023884 (UMLS CUI [1,2])
C2745955 (UMLS CUI [1,3])
C0087111 (UMLS CUI [1,4])
C0032756 (UMLS CUI [1,5])
C1948053 (UMLS CUI [1,6])
C0304229 (UMLS CUI [1,7])
C0808070 (UMLS CUI [1,8])
Start Date Investigational Product Not applicable (Liver event occured after treatment period)
Item
Not applicable
boolean
C0808070 (UMLS CUI [1,1])
C0304229 (UMLS CUI [1,2])
C1272460 (UMLS CUI [1,3])
End date of investigational product if liver event occured after treatment period
Item
End Date Investigational Product
date
C0877248 (UMLS CUI [1,1])
C0023884 (UMLS CUI [1,2])
C2745955 (UMLS CUI [1,3])
C0087111 (UMLS CUI [1,4])
C0032756 (UMLS CUI [1,5])
C1948053 (UMLS CUI [1,6])
C0304229 (UMLS CUI [1,7])
C0806020 (UMLS CUI [1,8])
End Date Investigational Product Not applicable (Liver event occured after treatment period)
Item
Not applicable
boolean
C0304229 (UMLS CUI [1,1])
C0806020 (UMLS CUI [1,2])
C1272460 (UMLS CUI [1,3])
Item Group
Pharmacokinetics
C0031327 (UMLS CUI-1)
Item
Was a pharmacokinetic blood sample obtained?
text
C0031328 (UMLS CUI [1,1])
C0005834 (UMLS CUI [1,2])
Pharmacokinetic blood sample
Code List
Was a pharmacokinetic blood sample obtained?
CL Item
Yes (Yes)
CL Item
No (No)
Date and time pharmacokinetic blood sample taken
Item
If a pharmacokinetic blood sample was obtained, date and time sample taken
datetime
C1277698 (UMLS CUI [1,1])
C0201734 (UMLS CUI [1,2])
C1264639 (UMLS CUI [1,3])
Date and time of last investigational product dose prior to PK sample
Item
If a pharmacokinetic blood sample was obtained, date and time of last investigational product dose prior to PK sample
datetime
C0304229 (UMLS CUI [1,1])
C1762893 (UMLS CUI [1,2])
C0946444 (UMLS CUI [1,3])
Sample Identifier/Sample Number if a pharmacokinetic blood sample was obtained
Item
If a pharmacokinetic blood sample was obtained, Sample Identifier/Sample Number
text
C1299222 (UMLS CUI [1])
Volver a la parte superior de la página 

Contacto

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial